The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

The opulent ballroom of the Willard Intercontinental Hotel is a regular stop on the high-dollar circuit of industry ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

Bernie Sanders plans a the bill to match Trump's order to lower drug prices, urging bipartisan support. Follow Newsweek's ...

Dr Vinay Prasad, an oncologist and outspoken critic of the FDA leadership and COVID-19 mandates has been named as the new ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

The US Food and Drug Administration has named Dr. Vinay Prasad ... shaped the Operation Warp Speed effort to rapidly develop ...

The Food and Drug Administration has asked Moderna for ... the company developed for flu and COVID-19, the latest sign vaccines may face additional regulatory scrutiny under new agency leadership.